Total Visits

Views
Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study68

Total Visits Per Month

July 2023August 2023September 2023October 2023November 2023December 2023January 2024February 2024March 2024April 2024May 2024
Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study01100563243

File Visits

Views
FBargiela_Discontinuation.pdf106

Top country views

Views
United States37
Sweden7
Ireland6
China5
Spain2
United Kingdom2
Argentina1
Canada1
Germany1
France1

Top cities views

Views
Ashburn10
Fairfield7
Dublin6
Cambridge5
Hangzhou5
Menlo Park4
San Diego3
A Coruña2
Mountain View2
Ann Arbor1